Overview
Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.
Description
Observational study collecting real-life clinico-biological data from patients with CML. Data are collected prospectively and retrospectively, from diagnosis and throughout the long-term follow-up of CML (follow up continues after treatment stopped).
Eligibility
Inclusion Criteria:
- Patient diagnosed for chronic myelocytic leukemia
Exclusion Criteria:
- CML allograft without TKI treatment
- Refusal or inability to sign the consent